» Articles » PMID: 31478210

Serial Exposure to Ethanol Drinking and Methamphetamine Enhances Glutamate Excitotoxicity

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2019 Sep 4
PMID 31478210
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A significant comorbidity exists between alcohol and methamphetamine (Meth) abuse but the neurochemical consequences of this co-abuse are unknown. Alcohol and Meth independently and differentially affect glutamatergic transmission but the unique effects of their serial exposure on glutamate signaling in mediating damage to dopamine neurons are unknown. Sprague-Dawley rats had intermittent voluntary access to 10% ethanol (EtOH) every other day and water over 28 days and were then administered a binge injection regimen of Meth or saline. EtOH drinking decreased the glutamate aspartate transporter and increased basal extracellular concentrations of glutamate within the striatum when measured after the last day of drinking. Ceftriaxone is known to increase the expression and/or activity of glutamate transporters in the brain and prevented both the decreases in glutamate aspartate transporter and the increases in basal extracellular glutamate when administered during EtOH drinking. EtOH drinking also exacerbated the acute increases in extracellular glutamate observed upon Meth exposure, the subsequent increases in spectrin proteolysis, and the long-term decreases in dopamine content in the striatum, all of which were attenuated by ceftriaxone administration during EtOH drinking only. These results implicate EtOH-induced increases in extracellular glutamate and corresponding decreases in glutamate uptake as mechanisms that contribute to the vulnerability produced by EtOH drinking and the unique neurotoxicity observed after serial exposure to Meth that is not observed with either drug alone. Open Science: This manuscript was awarded with the Open Materials Badge For more information see: https://cos.io/our-services/open-science-badges/.

Citing Articles

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.

Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L Int J Mol Sci. 2024; 25(12).

PMID: 38928227 PMC: 11203689. DOI: 10.3390/ijms25126521.


A novel monobactam lacking antimicrobial activity, MC-100093, reduces sex-specific ethanol preference and depressive-like behaviors in mice.

Leon B, Peyton L, Essa H, Wieden T, Marion N, Childers W Neuropharmacology. 2023; 232:109515.

PMID: 37001726 PMC: 10144181. DOI: 10.1016/j.neuropharm.2023.109515.


Combined and sequential effects of alcohol and methamphetamine in animal models.

Stafford A, Yamamoto B, Phillips T Neurosci Biobehav Rev. 2021; 131:248-269.

PMID: 34543650 PMC: 8642292. DOI: 10.1016/j.neubiorev.2021.09.019.


Toxic Effects of Methamphetamine on Perivascular Health: Co-morbid Effects of Stress and Alcohol Use Disorders.

Rodriguez E, Yamamoto B Curr Neuropharmacol. 2021; 19(12):2092-2107.

PMID: 34344290 PMC: 9185763. DOI: 10.2174/1570159X19666210803150023.


Alcohol Co-Administration Changes Mephedrone-Induced Alterations of Neuronal Activity.

Grotell M, den Hollander B, Jalkanen A, Torronen E, Ihalainen J, de Miguel E Front Pharmacol. 2021; 12:679759.

PMID: 33995109 PMC: 8115874. DOI: 10.3389/fphar.2021.679759.


References
1.
Thomas D, Kuhn D . Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity. J Pharmacol Exp Ther. 2005; 313(2):870-6. DOI: 10.1124/jpet.104.080242. View

2.
Blaker A, Yamamoto B . Methamphetamine-Induced Brain Injury and Alcohol Drinking. J Neuroimmune Pharmacol. 2017; 13(1):53-63. PMC: 5795265. DOI: 10.1007/s11481-017-9764-3. View

3.
Ottestad-Hansen S, Hu Q, Follin-Arbelet V, Bentea E, Sato H, Massie A . The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain. Glia. 2018; 66(5):951-970. DOI: 10.1002/glia.23294. View

4.
Chen X, Xing J, Jiang L, Qian W, Wang Y, Sun H . Involvement of calcium/calmodulin-dependent protein kinase II in methamphetamine-induced neural damage. J Appl Toxicol. 2016; 36(11):1460-7. DOI: 10.1002/jat.3301. View

5.
Rao P, Sari Y . Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem. 2012; 19(30):5148-56. PMC: 3486951. DOI: 10.2174/092986712803530511. View